Fact Based List:
Watson Health Perspectives: 6 considerations for value-based contracting for medications
Submitted by Charlene Ice on Mon, 11/23/2020 - 16:57
- How life sciences companies and payers will set the correct unit of value.
- Clarity about who will bear the administrative burden of documenting patient outcomes.
- Outcomes might unintentionally drive price increases.
- Value-based contracts could impact off-label utilization.
- How this information could affect quality indicators in the future.
- Addressing other regulatory issues, such as Medicaid’s “best price” policy.
Notes: From a blog by Arti Bhavsar PharmD, Linda Elbers PharmD, and Katherine Haverty.
Source: Watson Health Perspectives/IBM, November 6, 2020
Source URL: https://www.ibm.com/blogs/watson-health/considerations-contr...
List Ratings: |
Lists You Might Also Be Interested In
- Sage: 10 things to know about EHRs and value-based care
- World Economic Forum: 4 lessons for a successful switch to value-based healthcare
- David Axene: 6 Key Requirements for Successful Transition from FFS to Value-Based Reimbursement
- Erica McDermott: 5 Ways Value-Based Payment will Change the Face of Rehab Therapy
- Jacqueline Belliveau: The Top 10 Terms of Value-Based Purchasing
Login or register to post comments